Menu

Report Library

All Reports
Datamonitor Healthcare CV&Met: Atrial Fibrillation Market Spotlight

December 07, 2022

Atrial fibrillation (AF) is a common form of cardiac arrhythmia characterized by disordered electrical activity in the atria which results in ineffective contraction of the atria and supraventricular tachyarrhythmia. Turbulent blood flow in the heart due to irregular rhythm increases the risk of forming thrombi in the atria, primarily in the left atrial appendage, which can result in an embolic stroke. There are several adverse events associated with AF, such as systemic embolism, ischemic stroke, transient ischemic attack, and even death. Indeed, there is a five-fold increased risk of stroke in AF and a two-fold increase in mortality compared to non-AF patients. 

This Datamonitor Healthcare report contains a Market Spotlight module.

Indications Covered: Atrial Fibrillation/Flutter
Stroke Prevention in Atrial Fibrillation (SPAF)
Back to the top Back to the top